Correlation of daytime sleepiness with urine metabolites in patients with obstructive sleep apnea

Sleep and Breathing

Volumn 18, Issue 3, 2014, Pages 517-523

  Paik, Man Jeong ^a   Kim, Dong Kyu ^b   Nguyen, Duc Toan ^c   Lee, Gwang ^c,d   Rhee, Chae Seo ^e,f   Yoon, In Young ^e,f   Kim, Jeong Whun ^e,f  

^a Sunchon National University   (South Korea)

^b Hallym University College of Medicine   (South Korea)

^c Ajou University   (South Korea)

^d Ajou University School of Medicine   (South Korea)

^e Seoul National University Bundang Hospital   (South Korea)

^f Seoul National University College of Medicine   (South Korea)

Author keywords

Dopamine; Epworth sleepiness scale; Excessive daytime sleepiness; Metabolites; Obstructive sleep apnea; Urine

Indexed keywords

EID: 84891637446     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-013-0913-5     Document Type: Article

References (34)

1. Pagel JF (2009) Excessive daytime sleepiness. Am Fam Physician 79(5):391–396
2. Panossian LA, Veasey SC (2012) Daytime sleepiness in obesity: mechanisms beyond obstructive sleep apnea—a review. Sleep 35(5):605–615
3. Resta O, Foschino-Barbaro MP, Legari G, Talamo S, Bonfitto P, Palumbo A, Minenna A, Giorgino R, De Pergola G (2001) Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects. Int J Obes Relat Metab Disord 25(5):669–675
4. Kamil MA, Teng CL, Hassan SA (2007) Snoring and breathing pauses during sleep in the Malaysian population. Respirology 12(3):375–380
5. Seneviratne U, Puvanendran K (2004) Excessive daytime sleepiness in obstructive sleep apnea: prevalence, severity, and predictors. Sleep Med 5(4):339–343
6. Roure N, Gomez S, Mediano O, Duran J, Pena Mde L, Capote F, Teran J, Masa JF, Alonso ML, Corral J, Sanchez-Armengod A, Martinez C, Barcelo A, Gozal D, Marin JM, Barbe F (2008) Daytime sleepiness and polysomnography in obstructive sleep apnea patients. Sleep Med 9(7):727–731
7. Sun Y, Ning Y, Huang L, Lei F, Li Z, Zhou G, Tang X (2012) Polysomnographic characteristics of daytime sleepiness in obstructive sleep apnea syndrome. Sleep Breath 16(2):375–381
8. Jones BE (2003) Arousal systems. Front Biosci 8:s438–s451
9. Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14(6):540–545
10. Vernet C, Redolfi S, Attali V, Konofal E, Brion A, Frija-Orvoen E, Pottier M, Similowski T, Arnulf I (2011) Residual sleepiness in obstructive sleep apnoea: phenotype and related symptoms. Eur Respir J 38(1):98–105
11. Nguyen DT, Cho IS, Kim JW, Kim KR, Lee G, Paik MJ (2013) Acidic metabolite profiling analysis of catecholamine and serotonin as O-ethoxycarbonyl/tert-butyldimethylsilyl derivatives by gas chromatography–mass spectrometry. Biomed Chromatogr 27(2):216–221
12. Sukegawa M, Noda A, Sugiura T, Nakata S, Yoshizaki S, Soga T, Yasuda Y, Iwayama N, Nakai S, Koike Y (2005) Assessment of continuous positive airway pressure treatment in obstructive sleep apnea syndrome using 24-hour urinary catecholamines. Clin Cardiol 28(11):519–522
13. Elmasry A, Lindberg E, Hedner J, Janson C, Boman G (2002) Obstructive sleep apnoea and urine catecholamines in hypertensive males: a population-based study. Eur Res J 19(3):511–517
14. Hedner J, Darpo B, Ejnell H, Carlson J, Caidahl K (1995) Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. Eur Res J 8(2):222–229
15. Marrone O, Riccobono L, Salvaggio A, Mirabella A, Bonanno A, Bonsignore MR (1993) Catecholamines and blood pressure in obstructive sleep apnea syndrome. Chest 103(3):722–727
16. Ziegler MG, Mills PJ, Loredo JS, Ancoli-Israel S, Dimsdale JE (2001) Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea. Chest 120(3):887–893
17. Dimsdale JE, Coy T, Ancoli-Israel S, Mills P, Clausen J, Ziegler MG (1997) Sympathetic nervous system alterations in sleep apnea. The relative importance of respiratory disturbance, hypoxia, and sleep quality. Chest 111(3):639–642
18. Pinto P, Barbara C, Montserrat JM, Patarrao RS, Guarino MP, Carmo MM, Macedo MP, Martinho C, Dias R, Gomes MJ (2013) Effects of CPAP on nitrate and norepinephrine levels in severe and mild-moderate sleep apnea. BMC Pulm Med 13:13
19. Kema IP, de Vries EGE, Muskiet FAJ (2000) Clinical chemistry of serotonin and metabolites. J Chromatogr B Biomed Sci Appl 747(1–2):33–48
20. Tsunoda M (2006) Recent advances in methods for the analysis of catecholamines and their metabolites. Anal Bioanal Chem 386(3):506–514
21. Fang L, Lv Y, Sheng X, Yao S (2012) Sensitive, rapid and easy analysis of three catecholamine metabolites in human urine and serum by liquid chromatography tandem mass spectrometry. J Chromatogr Sci 50(5):450–456
22. Ishizuka T, Murotani T, Yamatodani A (2012) Action of modafinil through histaminergic and orexinergic neurons. Vitam Horm 89:259–278
23. Nguyen TL, Tian YH, You IJ, Lee SY, Jang CG (2011) Modafinil-induced conditioned place preference via dopaminergic system in mice. Synapse 65(8):733–741
24. Arnulf I, Leu-Semenescu S (2009) Sleepiness in Parkinson's disease. Parkinsonism Relat Fisord 15(Suppl 3):S101–S104
25. De Cock VC, Dauvilliers Y (2010) How to manage daytime sleepiness associated with Parkinson's disease. Rev Neurol 166(10):793–799
26. Kaynak D, Kiziltan G, Kaynak H, Benbir G, Uysal O (2005) Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment. Eur J Neurol 12(3):199–207
27. Chervin RD, Aldrich MS (1998) Characteristics of apneas and hypopneas during sleep and relation to excessive daytime sleepiness. Sleep 21(8):799–806
28. O'Connor GT, Caffo B, Newman AB, Quan SF, Rapoport DM, Redline S, Resnick HE, Samet J, Shahar E (2009) Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med 179(12):1159–1164
29. Goel N, Dinges DF (2011) Behavioral and genetic markers of sleepiness. J Clin Sleep Med 7(5 Suppl):S19–S21
30. Goel N, Banks S, Mignot E, Dinges DF (2010) DQB1*0602 predicts interindividual differences in physiologic sleep, sleepiness, and fatigue. Neurology 75(17):1509–1519
31. Zant JC, Leenaars CH, Kostin A, Van Someren EJ, Porkka-Heiskanen T (2011) Increases in extracellular serotonin and dopamine metabolite levels in the basal forebrain during sleep deprivation. Brain Res 1399:40–48
32. Sanchez-de-la-Torre M, Barcelo A, Pierola J, Esquinas C, de la Pena M, Duran-Cantolla J, Capote F, Masa JF, Marin JM, Vila M, Cao G, Martinez M, de Lecea L, Gozal D, Montserrat JM, Barbe F (2011) Plasma levels of neuropeptides and metabolic hormones, and sleepiness in obstructive sleep apnea. Respir Med 105(12):1954–1960
33. Miller MA (2011) Association of inflammatory markers with cardiovascular risk and sleepiness. J Clin Sleep Med 7(5 Suppl):S31–S33
34. Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, Mullington JM (2004) Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 43(4):678–683